within Pharmacolibrary.Drugs.N_NervousSystem.N04A_AnticholinergicAgents.N04AA04_Procyclidine;

model Procyclidine
  extends Pharmacolibrary.Drugs.ATC.N.N04AA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N04AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Procyclidine is an anticholinergic agent primarily used to treat symptoms of Parkinson's disease and extrapyramidal side effects of antipsychotic medications. It is approved in several countries for these indications, though its use has declined with newer treatments.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult population, as no robust human PK studies with model-derived parameters are published.</p><h4>References</h4><ol><li><p>Whiteman, PD, et al., &amp; Webster, A (1985). Pharmacokinetics and Pharmacodynamics of procyclidine in man. <i>European journal of clinical pharmacology</i> 28(1) 73–78. DOI:<a href=&quot;https://doi.org/10.1007/BF00635711&quot;>10.1007/BF00635711</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3987788/&quot;>https://pubmed.ncbi.nlm.nih.gov/3987788</a></p></li><li><p>Jang, EJ, et al., &amp; Shim, CK (2001). Nasal absorption of procyclidine in rats and dogs. <i>Archives of pharmacal research</i> 24(3) 219–223. DOI:<a href=&quot;https://doi.org/10.1007/BF02978261&quot;>10.1007/BF02978261</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11440081/&quot;>https://pubmed.ncbi.nlm.nih.gov/11440081</a></p></li><li><p>Brocks, DR (1999). Anticholinergic drugs used in Parkinson&#x27;s disease: An overlooked class of drugs from a pharmacokinetic perspective. <i>Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</i> 2(2) 39–46. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10952768/&quot;>https://pubmed.ncbi.nlm.nih.gov/10952768</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Procyclidine;
